Jean-Marie (John) Canan
Board Member
Grace Therapeutics, Inc. (GRCE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jean-Marie (John) Canan
Jean-Marie (John) Canan is recorded as Board Member at Grace Therapeutics, Inc. (GRCE). Grace Therapeutics, Inc. reported in an 8-K filed March 31, 2023 that Jean-Marie (John) Canan resigned as board of directors, effective March 30, 2023. Grace Therapeutics, Inc. reported in an 8-K filed September 29, 2022 that Jean-Marie (John) Canan was appointed director, effective September 28, 2022.
“On March 30, 2023, Mr. Jean-Marie (John) Canan resigned from the board of directors of Acasti Pharma Inc. (the "Company"), effective immediately.”
“Jean Marie (John) Canan, Jan D’Alvise, Donald Olds, Vimal Kavuru and Michael L. Derby were elected as directors of Acasti at the Meeting to serve for a term that expires at the 2023 annual meeting of Acasti shareholders or until their successors are duly elected or appointed, unless such office is earlier vacated in accordance with Acasti’s by-laws.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-28–present
-
2022-09-28–2023-03-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Grace Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Prashant Kohli CEO, Board Member
- Robert J. DelAversano CFO, Chief Accounting Officer
- A. Brian Davis Board Member
- Donald Olds Board Member
- Edward Neugeboren Board Member
- Jan D'Alvise Board Member
- Jan D’Alvise Board Member
- Jean Marie (John) Canan Board Member
- Michael L. Derby Board Member
- Roderick N. Carter Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.